Skip to main content
Journal cover image

Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi-Stakeholder Think Tank.

Publication ,  Journal Article
Torok, RD; Li, JS; Kannankeril, PJ; Atz, AM; Bishai, R; Bolotin, E; Breitenstein, S; Chen, C; Diacovo, T; Feltes, T; Furlong, P; Hanna, M ...
Published in: J Am Heart Assoc
February 10, 2018

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Heart Assoc

DOI

EISSN

2047-9980

Publication Date

February 10, 2018

Volume

7

Issue

4

Location

England

Related Subject Headings

  • Treatment Outcome
  • Stakeholder Participation
  • Patient Selection
  • Needs Assessment
  • Infant, Newborn
  • Infant
  • Hypolipidemic Agents
  • Humans
  • Endpoint Determination
  • Drug Development
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Torok, R. D., Li, J. S., Kannankeril, P. J., Atz, A. M., Bishai, R., Bolotin, E., … Hill, K. D. (2018). Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi-Stakeholder Think Tank. J Am Heart Assoc, 7(4). https://doi.org/10.1161/JAHA.117.007283
Torok, Rachel D., Jennifer S. Li, Prince J. Kannankeril, Andrew M. Atz, Raafat Bishai, Ellen Bolotin, Stefanie Breitenstein, et al. “Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi-Stakeholder Think Tank.J Am Heart Assoc 7, no. 4 (February 10, 2018). https://doi.org/10.1161/JAHA.117.007283.
Torok RD, Li JS, Kannankeril PJ, Atz AM, Bishai R, Bolotin E, et al. Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi-Stakeholder Think Tank. J Am Heart Assoc. 2018 Feb 10;7(4).
Torok, Rachel D., et al. “Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi-Stakeholder Think Tank.J Am Heart Assoc, vol. 7, no. 4, Feb. 2018. Pubmed, doi:10.1161/JAHA.117.007283.
Torok RD, Li JS, Kannankeril PJ, Atz AM, Bishai R, Bolotin E, Breitenstein S, Chen C, Diacovo T, Feltes T, Furlong P, Hanna M, Graham EM, Hsu D, Ivy DD, Murphy D, Kammerman LA, Kearns G, Lawrence J, Lebeaut B, Li D, Male C, McCrindle B, Mugnier P, Newburger JW, Pearson GD, Peiris V, Percival L, Pina M, Portman R, Shaddy R, Stockbridge NL, Temple R, Hill KD. Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi-Stakeholder Think Tank. J Am Heart Assoc. 2018 Feb 10;7(4).
Journal cover image

Published In

J Am Heart Assoc

DOI

EISSN

2047-9980

Publication Date

February 10, 2018

Volume

7

Issue

4

Location

England

Related Subject Headings

  • Treatment Outcome
  • Stakeholder Participation
  • Patient Selection
  • Needs Assessment
  • Infant, Newborn
  • Infant
  • Hypolipidemic Agents
  • Humans
  • Endpoint Determination
  • Drug Development